Pluristem Therapeutics, Inc. announced the appointments of two of its senior executives. These executive appointments support the company's growth and opportunities both on the clinical development front and with its big-pharma corporate partnerships. Yaky Yanay has been promoted to President and Chief Operating Officer.

Mr. Yanay joined Pluristem in 2006, serving as the Company's Chief Financial Officer in charge of financial strategy. Since March of 2012, Mr. Yanay has also served as the Company's Executive Vice President. Mr. Yanay is a member of the board of directors of Israel Advanced Technologies Industries.

Boaz Gur-Lavie has been appointed to the position of Chief Financial Officer and Secretary. Mr. Gur-Lavie recently joined Pluristem, serving as the Company's Vice President of Finance. Prior to joining Pluristem, Mr. Gur-Lavie was CFO of Abbott Informatics Division.